September 15th, 2023
This protocol outlines two methods for the quantitative analysis of mitophagy in pancreatic β-cells: first, a combination of cell-permeable mitochondria-specific dyes, and second, a genetically encoded mitophagy reporter. These two techniques are complementary and can be deployed based on specific needs, allowing for flexibility and precision in quantitatively addressing mitochondrial quality control.
Our protocol describes two complementary methods to study beta-cell mitophagy flux at the single-cell resolution via flow cytometry. The mt-Keima protocol utilizes a genetic mitophagy reporter, whereas the MtPhagy protocol combines three fluorescent dyes, which makes it easy to extrapolate to difficult-to-transfect cells in human samples. Assessments of mitophagy using traditional biochemical approaches and imaging approaches are both time consuming and challenging.
Thus, it's important to develop new, robust, and effective methods to study mitophagy flux in beta-cells. Both the mt-Keima and MtPhagy method are quantitative assessments that are efficient for studying mitophagy flux in pancreatic beta cells. So, the Soleimanpour lab focuses on the different mechanisms that drive pancreatic beta-cell failure and diabetes.
And we specifically focus on the different aspects of mitochondrial lifecycle, including mitophagy, to understand how defects in mitochondrial function drive the development of diabetes.
View the full transcript and gain access to thousands of scientific videos
This study presents two complementary methods for the quantitative analysis of mitophagy in pancreatic β-cells, focusing on understanding mitochondrial function in relation to diabetes. By employing flow cytometry, the research highlights the use of both a genetic mitophagy reporter and a combination of fluorescent dyes, facilitating enhanced analysis of mitophagy flux at a single-cell resolution.
Quantitative interrogation of mitophagy flux in pancreatic β-cells is critical for understanding mitochondrial quality control mechanisms that underpin insulin secretion and diabetes pathogenesis. The integration of genetic and dye-based flow cytometry approaches enables robust, scalable assessment of mitophagy in both engineered and primary human islet models. These complementary methods enhance predictive confidence in early discovery and translational diabetes research pipelines.
These methods position mitophagy flux quantification as a core capability from early discovery through preclinical diabetes research, enabling both hypothesis testing and translational continuity.